Also listed on Novartis Inflammasome Research, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Apr 18, 2037 · High confidence
20-year base term ends Apr 18, 2037
Held by Novartis AG
Filed Apr 1, 2022 as application 17/711,205 · Granted Sep 19, 2023
Base term, 20 years from filing
Today
2017
2037
Clock starts
Apr 18, 2017
Apr 18, 2017
Term ends
Apr 18, 2037
Apr 18, 2037
Granted
Sep 19, 2023
Sep 19, 2023
base term
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 18, 2017, when application PCT/US2017/028167, the earliest non-provisional in its chain, was filed (this one was filed Apr 1, 2022) | Apr 18, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 18, 2037 | High confidence |
This family
| Application PCT/US2017/028167 | PCT application no patent term | no patent term |
| US 11,339,136 | In force Apr 2037 | Apr 2037 |
| US 11,760,735 | this patent Apr 2037 | Apr 2037 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 11, 2022 Reel 61010, frame 316 | Roush, William R.; Ghosh, Shomir; Glick, Gary | IFM Therapeutics, Inc. | Services Agreement |
| Jul 11, 2022 Reel 60470, frame 199 | IFM Therapeutics, Inc. | IFM Therapeutics, LLC | Assignment of Assignor's Interest |
| Jul 11, 2022 Reel 60470, frame 361 | IFM Therapeutics, LLC | IFM Inflammation, Inc. | Assignment of Assignor's Interest |
| Jul 11, 2022 Reel 60622, frame 250 | IFM Inflammation, Inc. | IFM Tre, Inc. | Change of Name |
| Jul 11, 2022 Reel 60622, frame 309 | IFM Tre, Inc. | Novartis Inflammasome Research, Inc. | Change of Name |
| Jul 11, 2022 Reel 60470, frame 596 | Novartis Inflammasome Research, Inc. | Novartis AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2037
Term ends Apr 18, 2037. Maintenance fees still fall due before then
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.